IBEX 3520.041,90▲ +0,81%EuroStoxx 506485,67▲ +0,95%S&P 5007711,76▼ -0,25%€/$1,1596▲ +0,08%Brent90,18▲ +2,36%Bitcoin66.927▼ -0,17%

Breaking

Velle Capital launches Aude to finance complex real estate operationsMenorca positions itself as a high-end culinary destinationSturzenegger admits decline in formal employment and points to monotributoFormal employment falls in Argentina as monotributo growsATE demands ANSES to reopen salary negotiations and threatens with strikesThe ECB is considering moving bank money to the blockchain

Immunotherapy

Latest Immunotherapy news

1 article

Illustrative image: close-up of a laboratory sample with cancer cells and immune cells under a microscope

Companies

Scancell increases its capital raise to £13 million following strong demand

Scancell raises its UK placement to £13 million due to strong demand. It will issue 144.4 million new shares and merge with a SPAC to list on Nasdaq.

Beatriz Lorenzo Aguirre · 24 July 2026